Modeling of eicosanoid fluxes reveals functional coupling between cyclooxygenases and terminal synthases

Biophysical Journal

Volumn 106, Issue 4, 2014, Pages 966-975

  Kihara, Yasuyuki ^a,b   Gupta, Shakti ^b   Maurya, Mano R ^b   Armando, Aaron ^a   Shah, Ishita ^a   Quehenberger, Oswald ^a,c   Glass, Christopher K ^d   Dennis, Edward A ^a   Subramaniam, Shankar ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOOXYGENASE 2 INHIBITOR; ICOSANOID; ISOMERASE; KDO2 LIPID A; KDO2-LIPID A; LIPOCALIN; LIPOPOLYSACCHARIDE; LIPOXYGENASE; PROSTAGLANDIN R2 D ISOMERASE; PROSTAGLANDIN R2 D-ISOMERASE; PROSTAGLANDIN SYNTHASE; THROMBOXANE SYNTHASE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; KINETICS; MACROPHAGE; METABOLISM; MOUSE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2 INHIBITORS; EICOSANOIDS; INTRAMOLECULAR OXIDOREDUCTASES; KINETICS; LIPOCALINS; LIPOPOLYSACCHARIDES; LIPOXYGENASE; MACROPHAGES; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; THROMBOXANE-A SYNTHASE;

EID: 84894442328     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2014.01.015     Document Type: Article

References (45)

1. E.A. Dennis Lipidomics joins the omics evolution Proc. Natl. Acad. Sci. USA 106 2009 2089 2090
2. R. Harkewicz, and E.A. Dennis Applications of mass spectrometry to lipids and membranes Annu. Rev. Biochem. 80 2011 301 325
3. E. Fahy, and S. Subramaniam E.A. Dennis Update of the LIPID MAPS comprehensive classification system for lipids J. Lipid Res. 50 Suppl 2009 S9 S14
4. C.D. Funk Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294 2001 1871 1875
5. Y. Kihara, and S. Ishii T. Shimizu Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor J. Exp. Med. 202 2005 853 863
6. Y. Kihara, and K. Yanagida T. Shimizu Platelet-activating factor production in the spinal cord of experimental allergic encephalomyelitis mice via the group IVA cytosolic phospholipase A2-lyso-PAFAT axis J. Immunol. 181 2008 5008 5014
7. T. Shimizu Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation Annu. Rev. Pharmacol. Toxicol. 49 2009 123 150
8. S. Narumiya, and G.A. FitzGerald Genetic and pharmacological analysis of prostanoid receptor function J. Clin. Invest. 108 2001 25 30
9. Y. Kihara, and T. Matsushita T. Shimizu Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis Proc. Natl. Acad. Sci. USA 106 2009 21807 21812
10. Y. Kihara, and T. Yokomizo T. Shimizu The leukotriene B4 receptor, BLT1, is required for the induction of experimental autoimmune encephalomyelitis Biochem. Biophys. Res. Commun. 394 2010 673 678
11. M.W. Buczynski, D.S. Dumlao, and E.A. Dennis Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology J. Lipid Res. 50 2009 1015 1038
12. J.E. Burke, and E.A. Dennis Phospholipase A2 structure/function, mechanism, and signaling J. Lipid Res. 50 Suppl 2009 S237 S242
13. W.L. Smith, D.L. DeWitt, and R.M. Garavito Cyclooxygenases: structural, cellular, and molecular biology Annu. Rev. Biochem. 69 2000 145 182
14. N. Ueno, and M. Murakami I. Kudo Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2 J. Biol. Chem. 276 2001 34918 34927
15. K. Atarashi, and J. Nishimura K. Takeda ATP drives lamina propria T(H)17 cell differentiation Nature 455 2008 808 812
16. F. Di Virgilio, and P. Chiozzi O.R. Baricordi Nucleotide receptors: an emerging family of regulatory molecules in blood cells Blood 97 2001 587 600
17. E.A. Dennis, and J. Cao G. Kokotos Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention Chem. Rev. 111 2011 6130 6185
18. K. Takeda, T. Kaisho, and S. Akira Toll-like receptors Annu. Rev. Immunol. 21 2003 335 376
19. T. Hirabayashi, T. Murayama, and T. Shimizu Regulatory mechanism and physiological role of cytosolic phospholipase A2 Biol. Pharm. Bull. 27 2004 1168 1173
20. B. Samuelsson, R. Morgenstern, and P.J. Jakobsson Membrane prostaglandin E synthase-1: a novel therapeutic target Pharmacol. Rev. 59 2007 207 224
21. P. Jüni, and L. Nartey M. Egger Risk of cardiovascular events and rofecoxib: cumulative meta-analysis Lancet 364 2004 2021 2029
22. O. Quehenberger, and A.M. Armando E.A. Dennis Lipidomics reveals a remarkable diversity of lipids in human plasma J. Lipid Res. 51 2010 3299 3305
23. E.A. Dennis, and R.A. Deems S. Subramaniam A mouse macrophage lipidome J. Biol. Chem. 285 2010 39976 39985
24. S. Subramaniam, and E. Fahy M.R. Maurya Bioinformatics and systems biology of the lipidome Chem. Rev. 111 2011 6452 6490
25. D.S. Dumlao, and M.W. Buczynski E.A. Dennis High-throughput lipidomic analysis of fatty acid derived eicosanoids and n-acylethanolamines Biochim. Biophys. Acta 1811 2011 724 736
26. P. Baldi, and A.D. Long A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes Bioinformatics 17 2001 509 519
27. S. Gupta, and M.R. Maurya S. Subramaniam An integrated model of eicosanoid metabolism and signaling based on lipidomics flux analysis Biophys. J. 96 2009 4542 4551
28. H. Kitano, and A. Funahashi K. Oda Using process diagrams for the graphical representation of biological networks Nat. Biotechnol. 23 2005 961 966
29. E. Sabidó, and O. Quehenberger R. Aebersold Targeted proteomics of the eicosanoid biosynthetic pathway completes an integrated genomics-proteomics-metabolomics picture of cellular metabolism Mol. Cell. Proteomics 11 2012 014746
30. A. Grkovich, and C.A. Johnson E.A. Dennis Lipopolysaccharide-induced cyclooxygenase-2 expression in human U937 macrophages is phosphatidic acid phosphohydrolase-1-dependent J. Biol. Chem. 281 2006 32978 32987
31. S. Gupta, and M.R. Maurya S. Subramaniam Integration of lipidomics and transcriptomics data towards a systems biology model of sphingolipid metabolism BMC Syst. Biol. 5 2011 26
32. M.W. Buczynski, and D.L. Stephens E.A. Dennis TLR-4 and sustained calcium agonists synergistically produce eicosanoids independent of protein synthesis in RAW264.7 cells J. Biol. Chem. 282 2007 22834 22847
33. Y. Kita, and T. Takahashi T. Shimizu Pathway-oriented profiling of lipid mediators in macrophages Biochem. Biophys. Res. Commun. 330 2005 898 906
34. K. Yang, and W. Ma L. Lai Dynamic simulations on the arachidonic acid metabolic network PLOS Comput. Biol. 3 2007 e55
35. K. Yang, and H. Bai C. Tang Finding multiple target optimal intervention in disease-related molecular network Mol. Syst. Biol. 4 2008 228
36. R. Langenbach, and S.G. Morham O. Smithies Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration Cell 83 1995 483 492
37. R.A. Mitchell, and H. Liao R. Bucala Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response Proc. Natl. Acad. Sci. USA 99 2002 345 350
38. L. Boulet, and M. Ouellet N. Méthot Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile J. Biol. Chem. 279 2004 23229 23237
39. Y. Urade, and M. Ujihara O. Hayaishi Mast cells contain spleen-type prostaglandin D synthetase J. Biol. Chem. 265 1990 371 375
40. M. Lazarus, and B.K. Kubata O. Hayaishi Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages Arch. Biochem. Biophys. 397 2002 336 341
41. M. Murakami, and H. Naraba I. Kudo Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2 J. Biol. Chem. 275 2000 32783 32792
42. N. Ueno, and Y. Takegoshi M. Murakami Coupling between cyclooxygenases and terminal prostanoid synthases Biochem. Biophys. Res. Commun. 338 2005 70 76
43. H. Matsumoto, and H. Naraba S. Oh-ishi Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide- stimulated rat peritoneal macrophages Biochem. Biophys. Res. Commun. 230 1997 110 114
44. C.N. Serhan, S. Yacoubian, and R. Yang Anti-inflammatory and proresolving lipid mediators Annu. Rev. Pathol. 3 2008 279 312
45. C.N. Serhan Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution Prostaglandins Leukot. Essent. Fatty Acids 73 2005 141 162